afib and semaglutide 🫀 𝐍𝐞𝐰 𝐝𝐚𝐭𝐚 𝐨𝐧 𝐬𝐞𝐦𝐚𝐠𝐥𝐮𝐭𝐢𝐝𝐞 & 𝐚𝐭𝐫𝐢𝐚𝐥 𝐟𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧! In our a meta-analysis of 26 RCTs (~49,000 pts), reduced the risk of new-onset AF by 17%. 📉 Benefit was independent of age Multiple GLP-1 drugs linked to

The researchers compared the mean percentage change in body weight with 7.2 mg semaglutide vs placebo

Understanding your genetic profile helps PlexusDx providers optimize starting doses and titration schedules, reducing side effects while maximizing weight loss

Adequate hydration, electrolyte intake, and consistent meal timing are essential supports during the adjustment phase

These new vials not only help us meet the high demand for our obesity medicine, but also broaden access for patients seeking a safe and effective treatment option, Patrik Jonsson, president of Lilly Cardiometabolic Health and Lilly USA, said in a statement